Praxis precision medicines provides corporate update and reports third quarter 2021 financial results

Enrollment on track for 1h22 topline results for prax-114 phase 2/3 monotherapy mdd aria study and for prax-114 phase 2 dose-ranging mdd acapella study
PRAX Ratings Summary
PRAX Quant Ranking